IRLAB Therapeutics’ Trading on Nasdaq Stockholm Main Market

Paolo Bossi

MAQS has advised IRLAB Therapeutics AB. IRLAB Therapeutics AB has been admitted to trading the Company’s shares of series A on Nasdaq Stockholm Main Market. IRLAB…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Paolo Bossi

…

This content is for Standard 1 Year members only.
Login Join Now